Target intelligence / Profile preview

Aldehyde dehydrogenase, mitochondrial (ALDH2) (ALDH2)

Target
ALDH2
Molecular classification
Enzyme, Oxidoreductase, Aldehyde dehydrogenase family
01

Overview

Mitochondrial aldehyde dehydrogenase 2 (ALDH2) is a critical enzyme located in the mitochondrial matrix, primarily known for its role in the second stage of ethanol metabolism. It catalyzes the oxidation of acetaldehyde, a toxic and carcinogenic intermediate, into the less harmful acetate [1, 3, 10]. Beyond alcohol metabolism, ALDH2 serves as a vital detoxifying agent for reactive aldehydes generated during lipid peroxidation, such as 4-hydroxy-2-nonenal (4-HNE), which are implicated in oxidative stress and cellular damage [2, 6, 11]. A common genetic polymorphism, ALDH2*2 (rs671), results in a nearly inactive enzyme and is highly prevalent in East Asian populations, leading to alcohol flushing syndrome and increased susceptibility to esophageal cancer and cardiovascular diseases [5, 14, 16]. In clinical practice, ALDH2 is targeted by the inhibitor disulfiram to treat alcohol use disorder by causing an accumulation of acetaldehyde and subsequent unpleasant physiological reactions [13, 17, 19]. Emerging therapeutic strategies focus on ALDH2 activators, such as Alda-1, which aim to enhance the enzyme's activity to protect against ischemia-reperfusion injury in the heart and brain, as well as neurodegenerative conditions like Alzheimer's disease [4, 11, 15].

Other names
ALDH-E2ALDHIALDMAldehyde dehydrogenase 2 family memberMitochondrial aldehyde dehydrogenase
02

Mechanism of action

ALDH2 is targeted through two primary pharmacological approaches: inhibition and activation. Inhibitors like disulfiram block the enzyme's ability to metabolize acetaldehyde, leading to its toxic accumulation and inducing aversive symptoms (flushing, nausea) to deter alcohol consumption [13, 17]. Conversely, activators like Alda-1 enhance the enzyme's catalytic efficiency, particularly in individuals with the ALDH2*2 variant, to accelerate the detoxification of reactive aldehydes and mitigate oxidative damage in cardiovascular and neurodegenerative diseases [2, 4, 14]. Additionally, ALDH2 acts as a bioactivating enzyme for nitroglycerin, converting it into nitric oxide [7, 16].

03

Biological functions

Ethanol metabolism (acetaldehyde oxidation)Detoxification of reactive aldehydes (e.g., 4-HNE, MDA)Antioxidant defenseRegulation of autophagy and cell deathMetabolism of neurotransmitter metabolites (DOPAL, DOPGAL)Clearance of endogenous formaldehyde
04

Disease associations

Alcohol use disorderAlcohol flushing syndromeEsophageal cancerMyocardial ischemia-reperfusion injuryAlzheimer's diseaseParkinson's diseaseFanconi anemiaHypertensionStroke
05

Safety considerations

Disulfiram-ethanol reaction (severe hypotension, tachycardia, vomiting)Increased risk of esophageal and upper aerodigestive tract cancers in ALDH2-deficient individuals who consume alcoholReduced clinical efficacy of nitroglycerin in ALDH2*2 carriersPotential for disulfiram-like reactions with certain antibiotics (e.g., metronidazole, cephalosporins)
06

Interacting drugs

Disulfiram

7 more in the full profile.

07

Biomarkers

ALDH2*2 polymorphism (rs671)Blood acetaldehyde levels4-hydroxy-2-nonenal (4-HNE) protein adductsAlcohol flushing response

Beyond the preview

Go deeper on Aldehyde dehydrogenase, mitochondrial (ALDH2) (ALDH2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aldehyde dehydrogenase, mitochondrial (ALDH2) (ALDH2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call